NCT06365658 Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective
| NCT ID | NCT06365658 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bartosz M. Radtke |
| Condition | Aphasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-07-03 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2023-07-03 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate cognitive functioning profiles in adults with neurologically recognized aphasic syndromes and general population. The study group consist of minimal 600 adults (over 18 y.o.) who will be examined by qualified diagnosticians. Participants will be evaluated with tasks related to the studied variables: memory, learning and language. Furthermore informations regarding past and present health condition will be collected from participants. The main questions it aims to answer are: 1. What is the profile of memory and learning among polish adults? 2. Do gender and age moderates patterns of memory and learning functioning among polish adults? 3. What is a specific pattern of language functioning in adults with neurologically recognized aphasic syndromes? 4. Do gender moderates specific patterns of language functioning in adults with neurologically recognized aphasic syndromes? Researchers will compare the following groups of adults: 1. general population/control group 2. with neurologically recognized aphasic syndromes 3. seniors (over 60 y.o.)
Eligibility Criteria
Inclusion criteria for general population/control group: * age from 18 to 60 y.o. Inclusion criteria for neurologically recognized aphasic syndromes * age above 18 y.o. * neurologically recognized aphasic syndromes Inclusion criteria for seniors: * age above 60 y.o. Exclusion criteria for general population/control group: * age less then 18 y.o. * neurologically recognized aphasic syndromes Exclusion criteria for neurologically recognized aphasic syndromes * age less then 18 y.o. * no neurologically recognized aphasic syndromes Exclusion criteria for seniors * age less then 60 y.o. * diseases of the nervous system, such as: stroke, craniocerebral trauma, neuroinfections, neurodegenerative diseases * mental disorders such as depression, psychotic disorders, anxiety disorders, addictions
Contact & Investigator
Urszula Sajewicz-Radtke, Ph.D.
STUDY DIRECTOR
Laboratory of Psychological and Educational Tests
Frequently Asked Questions
Who can join the NCT06365658 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aphasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06365658 currently recruiting?
Yes, NCT06365658 is actively recruiting participants. Contact the research team at nowicki@pracowniatestow.pl for enrollment information.
Where is the NCT06365658 trial being conducted?
This trial is being conducted at Gdansk, Poland.
Who is sponsoring the NCT06365658 clinical trial?
NCT06365658 is sponsored by Bartosz M. Radtke. The principal investigator is Urszula Sajewicz-Radtke, Ph.D. at Laboratory of Psychological and Educational Tests. The trial plans to enroll 600 participants.